—

GALDERMA GROUP AG(GALDY)— 同業公司組

數據截至2026-09-24 — 評分每個交易日晚間重新計算。分組標準=首先為共同的Closelook指數成分,其次為產業。Closelook研究日記,不構成投資建議。

GALDERMA GROUP AG的Closelook綜合評分為54/100,在同業公司組內排名第8位(共11家)——組內評分最高的是Halozyme Therapeutics Inc(74/100)。

名稱綜合動能品質估值訊號距52週高點
GALDY GALDERMA GROUP AG54405827info15.1%
ROVI.MC Laboratorios Farmaceuticos ROVI60237652info30.2%
LNTH Lantheus Holdings Inc60667459info10.9%
KNSA Kiniksa Pharmaceuticals Ltd56905721info9.2%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock54895742ok6.5%
BHC.TO Bausch Health Companies Inc54507084info28.1%
ALM.MC Almirall S.A.52234466warn23.9%
HALO Halozyme Therapeutics Inc74969445ok1.4%
DXCM DexCom Inc66858036neutral5.2%
ARGX argenx NV ADR64747327ok10.3%
ONC BeiGene, Ltd.64796332ok6.6%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-09-24

Quick answers

GALDERMA GROUP AG在Closelook涵蓋範圍內的同業公司有哪些?

分組首先根據共同的Closelook指數成分,其次根據產業:Laboratorios Farmaceuticos ROVI (ROVI.MC)、Lantheus Holdings Inc (LNTH)、Kiniksa Pharmaceuticals Ltd (KNSA)、Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)、Bausch Health Companies Inc (BHC.TO)、Almirall S.A. (ALM.MC)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)等。

GALDY相對同業公司的評分如何?

GALDERMA GROUP AG的綜合評分為54/100,組內排名第8位(共11家),截至2026-09-24;組內最高綜合評分為Halozyme Therapeutics Inc(74/100)。Closelook評分為研究日記讀數,不構成評等或投資建議。

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.